One-Year Safety and Effectiveness of Insulin Degludec in Patients with Diabetes Mellitus in Routine Clinical Practice in India—TRUST (Tresiba Real-World Use Study)
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1019-p
Abstract: Insulin degludec (degludec) is a basal insulin with an ultra-long duration of action and low day-to-day variability in the glucose-lowering effect. The aim of this non-interventional, multicentric, prospective, post-authorization safety study (PASS) was to evaluate… read more here.
Keywords: insulin; bureau self; speaker9s bureau; private limited ... See more keywords
Reasons for Discontinuation of Insulin Therapy—Results from the International Diabetes Management Practices Study (IDMPS)
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1026-p
Abstract: Adherence to insulin therapy is often suboptimal. Understanding patients’ perspectives on drug adherence is essential for identification of barriers to therapy. The IDMPS is a global observational survey on the management of people with type… read more here.
Keywords: advisory panel; speaker9s bureau; self; panel self ... See more keywords
Prevalence of Obesity in the U.S. Adult Population—An Analysis of National Health and Nutrition Examination Surveys, 2003–2012
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1679-p
Abstract: Obesity is associated with increased CV risk. Using data from National Health and Nutrition Examination Surveys (NHANES; 2003-2012), we estimated frequency and prevalence of obesity in U.S. adults (≥20 years). Participants in 5 NHANES surveys… read more here.
Keywords: obesity; speaker9s bureau; bureau self; prevalence ... See more keywords
Reduced Rate of Acute Complications with Tubeless Insulin Pump Use—Data from 2,640 Patients in the German/Austrian DPV Registry
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1695-p
Abstract: Little is known about the rates of acute complications when switching from MDI or traditional insulin pumps to tubeless insulin pump therapy. The German/Austrian Diabetes patients follow-up-registry (DPV) includes 2691 patients with type 1 (n=2640),… read more here.
Keywords: pump; insulin; speaker9s bureau; bureau self ... See more keywords
Individual and Combined Glucose-Lowering Effects of Glucagon Receptor Antagonism and Sodium-Glucose Cotransporter 2 Inhibition
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1942-p
Abstract: Studies suggest that sodium-glucose cotransporter 2 inhibitors (SGLT2i) induce hyperglucagonemia, which might counteract its glucose-lowering ability in type 2 diabetes. In a randomized, placebo-controlled, double-dummy, double-blinded, cross-over study, 12 middle-aged patients with type 2 diabetes… read more here.
Keywords: advisory panel; bureau self; speaker9s bureau; self ... See more keywords
Mortality Risk in Adults With and Without Type 2 Diabetes after 18 Years of Follow-up in Northern Spain—The Asturias Study
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-199-lb
Abstract: Objective: People who develop type 2 diabetes (T2D) have higher mortality risk. Regarding Asturias Study, after 18 years of follow-up, we have estimated all-cause, cardiovascular and cancer mortality-risks according to categories of impaired glucose metabolism.… read more here.
Keywords: asturias study; mortality risk; speaker9s bureau; mortality ... See more keywords
Identification and Analysis of a Novel Glucose Toxicity–Sensitive Gene in Pancreatic ß Cell
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-2144-p
Abstract: Chronic hyperglycemia in type 2 diabetes (T2D) causes pancreatic β-cell dysfunction, which is well known as glucose toxicity (GT), whereas the treatment of T2D improves that dysfunction. However, its underlying molecular mechanism has not yet… read more here.
Keywords: bureau self; research support; speaker9s bureau; support self ... See more keywords
Visiting the Dentist May Help Diagnose Prediabetes
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-2379-pub
Abstract: Diabetes is a well known risk factor for periodontal and dental diseases. Despite increasing diabetes awareness, up to a third of diabetes cases remain undiagnosed. We assumed that a visit at the dentist’s is an… read more here.
Keywords: diagnose prediabetes; help diagnose; speaker9s bureau; dentist ... See more keywords
Prevalence and Predictors of Residual Hypertriglyceridemia According to Statin Use in U.S. Adults with Diabetes
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-332-or
Abstract: Background: Hypertriglyceridemia (HTG) is associated with increased cardiovascular risk and is common in diabetes (DM); however, statin therapy remains the primary treatment in most with moderate HTG. We examined the extent of residual HTG despite… read more here.
Keywords: statin use; bureau self; self amarin; speaker9s bureau ... See more keywords
IDegAsp Improves Glycemic Control with Minimal Hypoglycemia—An Indian Real-World Study in T2D Subjects
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-389-p
Abstract: Background: IDegAsp is the first insulin co-formulation constituting 70% insulin degludec and 30% insulin aspart. In contrast to conventional premix analogues, degludec component of IDegAsp lowers variability, fasting glucose with comparable glycemic control and fewer… read more here.
Keywords: t2d subjects; real world; bureau self; speaker9s bureau ... See more keywords
Diabetes Mellitus and High Triglycerides Are Significant Predictors of Major Cardiovascular Events and Increased Health Care Costs and Resource Utilization—A Real-World Analysis of High-Risk Statin-Treated Patients
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-416-p
Abstract: Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality in patients with diabetes. We investigated real-world impact of high triglycerides (TG) and diabetes on cardiovascular (CV) outcomes and costs. Methods: This… read more here.
Keywords: real world; bureau self; self amarin; speaker9s bureau ... See more keywords